By name: managing-enhanced-recovery-protocols language: en description: Implements ERAS pathway elements with compliance tracking across preop, intraop, and postop phases. Use when applying ERAS protocols, tracking pathway compliance, or optimizing surgical recovery. tags:
- management
- surgery
- compliance
- surgical
metadata:
author: casemark
practice_areas:
- General Surgery
- Surgical Subspecialties document_types:
- Management Report skill_modes:
- Management
- Coordination
Managing Enhanced Recovery Protocols
Implements ERAS pathway elements with compliance tracking across preop, intraop, and postop phases.
Why This Skill Exists
Enhanced Recovery After Surgery (ERAS) protocols are evidence-based, multimodal perioperative care pathways that significantly reduce complications, length of stay, and healthcare costs. The ERAS Society has published guidelines for over 20 surgical specialties, and meta-analyses consistently demonstrate 30-50% reduction in complications and 1-2 day reduction in length of stay when compliance exceeds 70%. ACS Strong for Surgery and CMS bundled payment models increasingly incentivize ERAS adoption.
However, ERAS implementation fails when elements are applied inconsistently. Studies show the dose-response relationship is real: each 10% increase in ERAS compliance produces a measurable reduction in complications. Institutions that track compliance element-by-element and feed data back to care teams achieve sustained improvement. This skill provides the complete ERAS framework across all three phases with a structured compliance tracking system.
Checkpoint A: Pre-Draft Intake (Mandatory)
- What surgical procedure is planned? Default: [VERIFY]
- Which ERAS Society guideline applies (colorectal, hepatobiliary, pancreatic, gastric, gynecologic, urologic, thoracic, other)? Default: colorectal
- What is the patient's ASA class and relevant comorbidities? Default: ASA II
- Does the patient have diabetes, and if so, what is the current A1c? Default: no diabetes
- Is the patient a current smoker or active substance user? Default: no
- What is the patient's nutritional status (BMI, albumin)? Default: albumin ≥3.0, BMI 18.5-30
- Has the patient been counseled on the ERAS pathway expectations? Default: not yet
- Is the patient on chronic opioids? Default: no
Documents to Request
- Applicable ERAS Society guideline document
- Institutional ERAS order set
- Patient education materials for the specific ERAS pathway
- Preoperative assessment results (labs, imaging, nutritional screen)
- Anesthesia plan aligned with ERAS elements
- Prior ERAS compliance data for the surgical team (if available)
Step 1: Preoperative ERAS Elements
Implement all preoperative elements with documentation:
| Element | Protocol | Evidence Grade |
|---|---|---|
| Patient education | Structured counseling on pathway expectations, discharge goals, pain management approach | Strong |
| Nutritional optimization | Screen all patients; oral nutritional supplements x14 days preop if malnourished (albumin <3.0) | Strong |
| Smoking cessation | ≥4 weeks before elective surgery; offer pharmacotherapy (varenicline, NRT) | Strong |
| Alcohol cessation | ≥4 weeks before elective surgery | Strong |
| Prehabilitation | Exercise program 2-4 weeks preop for high-risk patients (functional capacity <4 METs) | Moderate |
| Anemia management | Treat iron deficiency (IV iron if <4 weeks to surgery); target Hgb >12 g/dL | Strong |
| Carbohydrate loading | 800 mL clear carbohydrate drink evening before surgery; 400 mL 2-3 hours preop | Strong |
| No prolonged fasting | Clear liquids up to 2 hours before anesthesia; solids up to 6 hours | Strong |
| No routine bowel prep | Mechanical bowel prep NOT recommended as standard for colorectal (oral antibiotics with MBP may reduce SSI — use per institutional protocol) | Strong |
| VTE risk assessment | Caprini score calculated; prophylaxis plan documented | Strong |
| Antibiotic prophylaxis plan | Agent selected per SCIP guidelines; timing planned for 60 min pre-incision | Strong |
Document compliance for each element: YES (completed) / NO (omitted with reason) / N/A (not applicable).
Step 2: Intraoperative ERAS Elements
| Element | Protocol | Evidence Grade |
|---|---|---|
| Short-acting anesthetic agents | Propofol, remifentanil, desflurane/sevoflurane preferred; avoid long-acting benzodiazepines | Strong |
| Antibiotic administration | Given within 60 min of incision; re-dose if case >4h or EBL >1500 mL | Strong |
| Surgical approach | Minimally invasive approach preferred when oncologically equivalent | Strong |
| Goal-directed fluid therapy (GDFT) | Use esophageal Doppler or arterial waveform analysis to guide IV fluids; avoid overhydration (target zero balance) | Strong |
| Normothermia | Active warming (forced air); maintain temp ≥36.0°C throughout | Strong |
| Restrictive IV fluids | Balanced crystalloid (LR preferred over NS); avoid >3L unless GDFT-directed | Strong |
| Nasogastric tube | Do NOT place routinely; if placed intraop, remove before extubation | Strong |
| Peritoneal drainage | Do NOT place drains routinely in colorectal surgery | Moderate |
| Regional analgesia | Thoracic epidural or TAP block as part of multimodal plan | Strong |
| PONV prophylaxis | Multimodal: dexamethasone 4-8 mg + ondansetron 4 mg; add scopolamine patch for high-risk patients | Strong |
Document each element's compliance intraoperatively. The anesthesia record and circulating nurse documentation should capture fluid volumes, temperature, antibiotic timing, and PONV prophylaxis.
Step 3: Postoperative ERAS Elements (POD 0-1)
| Element | Protocol | Evidence Grade |
|---|---|---|
| Early oral intake | Clear liquids POD 0 (within 4h of surgery); regular diet POD 1 | Strong |
| Early mobilization | Out of bed POD 0 (minimum 2h); ambulate 4x/day starting POD 1 | Strong |
| Multimodal analgesia | Scheduled acetaminophen + NSAID; opioids PRN only; epidural or TAP block | Strong |
| Opioid-sparing approach | Target ≤40 mg OME/day by POD 2; no basal PCA rate | Strong |
| Early Foley removal | Remove urinary catheter POD 1 (or intraop if case <2h with low fluid volume) | Strong |
| VTE prophylaxis | LMWH or UFH per Caprini score; SCDs continuous until ambulatory | Strong |
| No routine NGT | If ileus develops, attempt conservative management (ambulation, chewing gum) before NGT | Strong |
| Glycemic control | Maintain glucose <180 mg/dL; insulin protocol for diabetics | Strong |
| Chewing gum | Offer sugar-free gum TID (stimulates GI motility, reduces ileus) | Moderate |
| Discharge planning | Begin discharge planning POD 0; set patient expectations for discharge criteria | Strong |
Track and document hourly ambulation minutes and oral intake volumes.
Step 4: Discharge Criteria and Extended Recovery
Standardized Discharge Criteria (all must be met)
- Tolerating regular diet without nausea/vomiting
- Pain controlled on oral medications (NRS ≤4, meeting functional goals)
- Ambulating independently at baseline level
- Afebrile (T <38.0°C) for ≥24 hours
- No clinical signs of surgical complication
- Bowel function returned (passing flatus or BM — for GI surgery)
- Drain output acceptable for removal or patient educated on home drain care
- VTE prophylaxis plan for post-discharge documented (if extended course indicated)
- Follow-up appointment scheduled
- Patient demonstrates understanding of discharge instructions
Expected Length of Stay by ERAS Protocol
| Procedure | Traditional LOS | ERAS Target LOS |
|---|---|---|
| Laparoscopic colectomy | 5-7 days | 2-3 days |
| Open colectomy | 7-10 days | 4-5 days |
| Pancreaticoduodenectomy | 10-14 days | 7-8 days |
| Laparoscopic cholecystectomy | 1-2 days | Same-day or 1 day |
| Total hip/knee replacement | 3-4 days | 1-2 days |
Step 5: Compliance Tracking and Quality Improvement
Element-Level Compliance Dashboard
Track compliance for each ERAS element per patient and aggregate by surgeon/service:
Compliance Rate = (Elements Completed / Total Applicable Elements) x 100
Target: ≥80% overall compliance; no single element below 60%
Monthly ERAS Report Structure
- Volume: Number of patients on the ERAS pathway
- Compliance: Overall rate and element-by-element breakdown
- Outcomes:
- Average length of stay vs. ERAS target
- 30-day complication rate (Clavien-Dindo ≥ II)
- 30-day readmission rate
- ED visit rate within 30 days
- Opioid consumption (average OME at discharge)
- Variance analysis: Identify the lowest-compliance elements and root causes
- Action items: Targeted interventions for low-compliance elements
Common compliance failures and interventions:
| Low-Compliance Element | Common Root Cause | Intervention |
|---|---|---|
| Carbohydrate loading | Patient not instructed; drink not available | Pre-admit clinic provides drink at pre-op visit |
| Early mobilization POD 0 | Night admission to floor; nurse staffing | PT consult entered at time of booking |
| Early Foley removal | Order not written; nurse concern about retention | Auto-remove order in EHR at POD 1 06:00 |
| Multimodal analgesia | Opioids ordered first instead of non-opioids | Default order set with non-opioids pre-checked |
Checkpoint B: Post-Draft Alignment (Mandatory)
- Has every applicable ERAS element been documented as completed, omitted (with reason), or N/A?
- Is the overall compliance rate calculated and ≥80%?
- Are the expected LOS targets set and communicated to the patient and care team?
- Is the discharge criteria checklist being used to drive discharge decisions?
- Are monthly ERAS compliance and outcomes reports being generated?
Quality Audit
- Patient education on ERAS pathway documented preoperatively
- Nutritional screening completed; supplements initiated if indicated
- Carbohydrate loading administered per protocol
- Fasting limited to 2h clear liquids / 6h solids
- Antibiotic prophylaxis given within 60 min of incision
- Goal-directed fluid therapy used intraoperatively
- Normothermia maintained (≥36.0°C)
- Minimally invasive approach used (or reason for open documented)
- PONV prophylaxis administered (multimodal)
- Early oral intake initiated POD 0
- Early mobilization documented (time out of bed POD 0)
- Multimodal analgesia with opioid-sparing approach documented
- Foley catheter removed POD 1 (or reason for delay documented)
- Discharge criteria checklist used
- ERAS compliance rate calculated per patient
Guidelines
- ERAS is a pathway, not a menu — the benefit comes from high compliance across ALL elements, not cherry-picking individual components. Each element omitted reduces the cumulative benefit.
- Carbohydrate loading and limited fasting are safe in non-diabetic patients without gastroparesis. For diabetics, modify the carbohydrate load volume and check glucose on arrival.
- Goal-directed fluid therapy reduces complications compared to both liberal and overly restrictive fluid strategies — the target is euvolemia, not a specific volume.
- Early oral intake on POD 0 is safe even after colorectal surgery — multiple RCTs and meta-analyses confirm this does not increase anastomotic leak rates.
- The single strongest predictor of ERAS success at the institutional level is compliance tracking with feedback to the care team — without measurement, compliance degrades to <50% within 6 months.
- Do not use ERAS target LOS as a discharge mandate — patients must meet all discharge criteria regardless of POD number.
- Extended VTE prophylaxis (28 days of LMWH) is recommended for major abdominal/pelvic cancer surgery per ERAS and ASCO guidelines.
- Engage the entire perioperative team (surgery, anesthesia, nursing, PT, pharmacy, nutrition) in ERAS education — compliance depends on every team member executing their elements.